share_log

復星醫藥:海外監管公告 - 關於股東部分股份解除質押的公告

FOSUN PHARMA: Overseas Regulatory Announcement - Announcement Regarding the Release of Pledged Shares by Shareholders

HKEX ·  Nov 27 11:08

Summary by Moomoo AI

截至2024年11月26日,復星高科技持有復星醫藥約35.99%的股份,其中部分A股已解除質押。此次解除質押的股份數量為1.2億股,占其持有股份的12.48%,占公司總股份的4.49%。解除後,復星高科技剩餘質押股份為5.338億股,占其持有股份的55.52%。\\n復星高科技及其一致行動人合計持有復星醫藥約36.23%的股份,解除質押後,質押股份餘額為5.338億股,占其持有股份的55.16%。復星高科技確認未來可能有質押計劃,將根據實際情況及法律要求履行告知義務。公司將按規定及時披露相關信息。\\n此次公告由復星醫藥董事會於2024年11月27日發布,董事長吳以芳代表公司確認公告內容的真實性、準確性和完整性,並承擔法律責任。
截至2024年11月26日,復星高科技持有復星醫藥約35.99%的股份,其中部分A股已解除質押。此次解除質押的股份數量為1.2億股,占其持有股份的12.48%,占公司總股份的4.49%。解除後,復星高科技剩餘質押股份為5.338億股,占其持有股份的55.52%。\\n復星高科技及其一致行動人合計持有復星醫藥約36.23%的股份,解除質押後,質押股份餘額為5.338億股,占其持有股份的55.16%。復星高科技確認未來可能有質押計劃,將根據實際情況及法律要求履行告知義務。公司將按規定及時披露相關信息。\\n此次公告由復星醫藥董事會於2024年11月27日發布,董事長吳以芳代表公司確認公告內容的真實性、準確性和完整性,並承擔法律責任。
As of November 26, 2024, Fosun Technology holds approximately 35.99% of Fosun Pharma's shares, of which part of the A shares have been released from pledge. The number of shares released from pledge is 0.12 billion shares, accounting for 12.48% of its held shares and 4.49% of the company's total shares. After the release, Fosun Technology's remaining pledged shares are 0.5338 billion shares, accounting for 55.52% of its held shares. Fosun Technology and its concerted actors collectively hold about 36.23% of Fosun Pharma's shares. After the release of the pledge, the remaining pledged shares amount to 0.5338 billion shares, accounting for 55.16% of its held shares. Fosun Technology confirms there may be future pledge plans, which will be carried out in accordance with actual circumstances and legal requirements. The company will disclose relevant information in a timely manner as required. This announcement was published by the board of directors of Fosun Pharma on November 27, 2024. Chairman Wu Yifang confirmed the authenticity, accuracy, and completeness of the announcement content on behalf of the company and bears legal responsibility.
As of November 26, 2024, Fosun Technology holds approximately 35.99% of Fosun Pharma's shares, of which part of the A shares have been released from pledge. The number of shares released from pledge is 0.12 billion shares, accounting for 12.48% of its held shares and 4.49% of the company's total shares. After the release, Fosun Technology's remaining pledged shares are 0.5338 billion shares, accounting for 55.52% of its held shares. Fosun Technology and its concerted actors collectively hold about 36.23% of Fosun Pharma's shares. After the release of the pledge, the remaining pledged shares amount to 0.5338 billion shares, accounting for 55.16% of its held shares. Fosun Technology confirms there may be future pledge plans, which will be carried out in accordance with actual circumstances and legal requirements. The company will disclose relevant information in a timely manner as required. This announcement was published by the board of directors of Fosun Pharma on November 27, 2024. Chairman Wu Yifang confirmed the authenticity, accuracy, and completeness of the announcement content on behalf of the company and bears legal responsibility.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more